Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2227 (LINC02227)

Target
LINC02227
Molecular classification
Long non-coding RNA (lncRNA), Intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2227 (LINC02227) is a long intergenic non-coding RNA (lincRNA), defined as an autonomously transcribed RNA transcript longer than 200 nucleotides that does not overlap with protein-coding genes. LINC02227 is part of the broader family of lncRNAs, characterized by their roles in regulating gene expression at multiple levels, including chromatin remodeling, transcriptional regulation, and RNA stabilization. Intergenic lncRNAs, such as LINC02227, can also function as competing endogenous RNAs (ceRNAs), which regulate mRNA stability and translation by interacting with microRNAs. Although LINC02227 has been identified as differentially expressed in certain diseases, including as upregulated in epicardial adipose tissue from patients with coronary artery disease, there is currently no evidence that it acts as a direct therapeutic target, receptor, enzyme, or biomarker. Its biological and pathological functions remain under investigation, as is the case for most newly annotated lincRNAs.

Other names
LINC02227
02

Biological functions

Regulation of gene expressionRNA stabilizationChromatin remodelingPotential competing endogenous RNA (ceRNA) activity
03

Disease associations

Potential involvement in cardiovascular disease (based on expression profiling in coronary artery disease; not yet an established therapeutic/disease biomarker)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2227 (LINC02227).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2227 (LINC02227).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call